Gastric Electric Stimulators Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Gastroparesis, a condition characterized by intractable nausea, chronic vomiting, and delayed stomach emptying, has found a promising treatment avenue in gastric electric stimulators. These programmable devices, powered by batteries, generate controlled electrical pulses to stimulate the antrum portion of the stomach's muscle wall. The market for these life-changing devices is witnessing substantial growth, with key manufacturers such as Medtronic Plc. and others contributing more than 50% of the revenue.

Expanding Horizons Through Acquisition and Collaboration

Medtronic Plc. and other industry leaders are at the forefront of this transformative medical technology, actively expanding their product portfolios through acquisitions, partnerships, and collaborations. These strategic moves aim to enhance their regional presence and further solidify their dominance in the global gastric electric stimulators market.

Advancements Fuel Growth Opportunities

Recent advancements in potential treatment options, techniques, and devices have broadened the spectrum of gastroparesis management. Innovations in gastrointestinal disorders, coupled with less invasive surgical approaches and robotic technology, offer promising growth opportunities in the gastric electric stimulators market.

Geriatric Population and Rising Prevalence Drive Demand

The geriatric population faces a higher risk of gastrointestinal diseases, contributing significantly to the demand for gastric electric stimulators. The increasing prevalence of gastroparesis, particularly related to diabetes and obesity, has led to a surge in surgical interventions for its treatment, consequently boosting the demand for these stimulators.

Economic Impact Spurs Demand

In the United States, the number of hospitalizations related to gastroparesis has surged, causing a substantial economic impact. This trend is expected to drive the demand for gastric stimulators in the near future.

Supportive Reimbursements and Government Spending

Favorable reimbursements, especially in underdeveloped and developing economies, have played a pivotal role in supporting the market for gastric electric stimulators. Additionally, increased government spending on healthcare infrastructure, as highlighted by the Centers for Medicare and Medicaid Services, is expected to further boost market growth.

Competitive Analysis

Leading players in the gastric electric stimulators market are focused on manufacturing technologically advanced products to enhance effectiveness and patient compliance. Profiles of key players include Medtronic Plc., ReShape Lifesciences, Inc., IntraPace Inc., Changzhou Ruishen Medical Equipment Co., Ltd, and others.

Market Segmentation

The report provides a detailed classification system for the gastric electric stimulators market, categorizing it based on product type, indication, end user, and geographical region. Gastric electric stimulators come in various forms, including low-frequency GES devices and high-frequency GES devices, and they serve multiple purposes, such as addressing conditions like gastroparesis and obesity.

In terms of indication, the gastric electric stimulators market is divided into categories such as gastroparesis, obesity, refractory nausea, and other related conditions. The end-user segments within this market encompass hospitals and outpatient centers, reflecting the healthcare facilities where these devices are utilized.

The analysis of the gastric electric stimulators market extends across different regions, including North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa (MEA), providing insights into its performance and dynamics in various parts of the world.


This product will be delivered within 1-3 business days.